Latest news
New to The Street NASDAQ MARKETSITE - ACCESS NewswireACCESS Newswire · Sat, 08 Aug 2026 16:03:05 GMTNew to The Street Show 766 Broadcasts Tonight at 6:30 PM ET on Bloomberg Television, Featuring BioVie's Bezisterim Parkinson's Disease Clinical Results - guardonline.comguardonline.com · Sat, 08 Aug 2026 16:01:36 GMTBezisterim Shows Improvements in Motor, Nonmotor Symptoms in Phase 2 SUNRISE-PD Trial - neurologylive.comneurologylive.com · Sat, 08 Aug 2026 10:17:30 GMTBioVie posts corporate presentation outlining bezisterim, BIV201 clinical programs in neurodegeneration, Long COVID, liver disease - BitgetBitget · Fri, 07 Aug 2026 10:56:32 GMTBioVie stock sinks on Phase IIb Parkinson’s trial data - Clinical Trials ArenaClinical Trials Arena · Fri, 07 Aug 2026 10:14:16 GMTBezisterim meets motor and non-motor endpoints in phase II early Parkinson's trial. - AllSciAllSci · Thu, 06 Aug 2026 16:12:09 GMTBioVie’s stock sinks 50% as company uses composite endpoint to make case for Parkinson’s program - Fierce BiotechFierce Biotech · Thu, 06 Aug 2026 13:40:09 GMTBioVie says Phase 2 SUNRISE-PD trial of bezisterim met primary endpoint - TipRanksTipRanks · Thu, 06 Aug 2026 13:36:05 GMT